Supplementary Figure S3 from Preclinical Evaluation of Bavdegalutamide (ARV-110), a Novel PROteolysis TArgeting Chimera Androgen Receptor Degrader
Authors:
- Lawrence B. SnyderLSLawrence B. Snyder
- Taavi K. NeklesaTNTaavi K. Neklesa
- Ryan R. WillardRWRyan R. Willard
- Deborah A. GordonDGDeborah A. Gordon
- Jennifer PizzanoJPJennifer Pizzano
- Nicholas VitaleNVNicholas Vitale
- Kaitlynn RoblingKRKaitlynn Robling
- Madeline A. DorsoMDMadeline A. Dorso
- Walid MoghrabiWMWalid Moghrabi
- Sean LandretteSLSean Landrette
- Richard GedrichRGRichard Gedrich
- Sang Hyun LeeSLSang Hyun Lee
Open Access
- 17 June 2026
- other
- Published by American Association for Cancer Research (AACR)